Identification and validation of a novel phagocytosis regulators-related signature with potential prognostic and immunotherapeutic value in patients with lung adenocarcinoma

Identification and validation of a novel phagocytosis regulators-related signature with potential prognostic and immunotherapeutic value in patients with lung adenocarcinoma

BackgroundLung adenocarcinoma (LUAD) is a malignant tumor that seriously affects the prognosis of patients. Tumor-associated macrophages (TAMs) play a vital role in the tumor microenvironment and can be used as a potential target for tumor therapy, and phagocytosis regulators (PRs) are particularly...

Full description

Bibliographic Details
Main Authors: Jingyang Li, Qinyun Du, Jiayi Sun, Li Xiang, Shaohui Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Oncology
Subjects:
lung adenocarcinoma
phagocytosis regulators
prognostic value
immunotherapeutic value
risk score
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.988332/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.988332/full

Similar Items